NEW DELHI: India’s rapidly expanding private healthcare sector is attracting billions of dollars in investment and widening access to advanced medical facilities, but rising treatment costs are fuelling concerns over whether critical care remains affordable for millions of people.
The country’s private healthcare industry has witnessed unprecedented growth in recent years, with hospitals adding thousands of beds, diagnostic chains expanding into smaller cities and healthcare companies attracting billions of dollars in investment.
In early August, Manipal Health, one of India’s largest multi-speciality hospital groups, raised nearly $1 billion through an initial public offering, highlighting investor confidence in the sector.
Between 2022 and 2024, healthcare and pharmaceutical companies recorded more than $30 billion in mergers, acquisitions and private equity transactions, according to industry data.
ALSO READ: India Faces 100% US Tariff Threat Over Russian Oil
However, a recent government panel report warned that the expansion has also created a growing affordability challenge. It found that treatment costs in private hospitals are often five to 10 times higher than in government facilities, with larger gaps reported for serious illnesses such as cancer, heart disease and kidney failure.
Vulnerable households
The report raised concerns over increasing commercialisation, uneven regulatory standards, excessive billing and rising costs for routine procedures, warning that vulnerable households could face severe financial pressure.
The panel recommended measures including regulation of treatment costs, standardised healthcare guidelines and greater oversight of private hospitals. Industry representatives, however, argued that price caps could discourage investment in a sector that requires significant capital.
Healthcare experts said stronger regulation should be accompanied by greater public investment to reduce dependence on expensive private facilities. India’s government health spending remains below targets outlined in national policy and international recommendations.
While private investment remains essential to expand healthcare capacity, policymakers face the challenge of balancing sector growth with ensuring that quality medical treatment remains accessible to ordinary citizens.
